PREVALENCE OF ADMISSIONS DUE TO AIDS IN A REFERENCE HOSPITAL IN THE STATE OF PARAÍBA
Article Sidebar
Main Article Content
Abstract
AIDS (Acquired Immune Deficiency Syndrome) is a condition of viral etiology caused by HIV, which compromises the individual's immune system. The objective of this study is to outline the profile of hospitalizations for Acquired Immunodeficiency Syndrome in a reference hospital managed by Empresa Brasileira e Serviços Hospitalares. An exploratory, transversal and retrospective approach was used, employing a quantitative and qualitative analysis. Data were collected from secondary sources, specifically DATASUS, which offers information on the profile of hospitalizations for Acquired Immunodeficiency Syndrome in a reference hospital in the state of Paraíba. During the prevalence calculation, it was observed that the prevalence of hospitalizations due to Acquired Immunodeficiency Syndrome corresponds to 33% of cases, highlighting the importance of prevention strategies, mass testing and intensification of policies to combat and prevent the disease. It is worth noting that despite advances, the disease represents an important challenge to Public Health, corresponding to a high morbidity and mortality rate in the country. AIDS represents one of the main causes of hospitalization for Notifiable Diseases, even with prevention strategies as well as campaign campaigns and early diagnosis suggesting intensification of these as well as greater coordination in the Health Care Network.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c). Conjuncture Bulletin (BOCA)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
AFRASHTEH, S. et al. “Factors associated with late antiretroviral therapy initiation among people living with HIV in southern Iran: a historical cohort study”. Frontiers in Public Health, vol. 10, 2022.
BOGDANIĆ, N. et al. “Timeliness of antiretroviral therapy initiation in the era before universal treatment”. Scientific Reports, vol. 1, n. 1, 2021.
BRASIL. Boletim Epidemiológico do Estado da Paraíba. Brasília: SINAN, 2023. Disponível em: . Acesso em: 26/10/2024.
BRASIL. Estatísticas Globais sobre HIV 2021. Brasília: Ministério da Saúde, 2023. Disponível em: . Acesso em: 26/10/2024.
CARMO, R. A. et al. “Subnotificação de óbitos por AIDS no Brasil: Linkage dos registros hospitalares com dados de declaração de óbito”. Ciência e Saúde Coletiva, vol. 4, n. 26, 2021.
CUNHA, A. P.; CRUZ, M. M.; PEDROZO, M. “Análise da tendência da mortalidade por HIV/AIDS segundo características sociodemográficas no Brasil, 2000 a 2018”. Ciência e Saúde Coletiva, vol. 27 2022.
FREDERICKSEN, R. J. et al. “Impact and correlates of sub-optimal social support among patients in HIV care”. AIDS Care, vol. 33, 2021.
GAMA, W. M. et al. “Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon”. BMC Infectious Diseases, vol. 21, n 2, 2021.
GARCIA E. C. et al. “Representações sociais de adolescentes sobre a transmissão do HIV/AIDS nas relações sexuais: vulnerabilidades e riscos”. Escola Anna Nery, n. 26, 2022.
LI, B. et al. “The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study”. BMC Public Health, vol. 24, n. 1, 2024.
LUCAS, M. C. V. et al. “Sobre o presente e o futuro da epidemia HIV/Aids: a prevenção combinada em questão”. Physis: Revista de Saúde Coletiva, vol. 33, 2023.
MACHADO, C. A. L. et al. “Epidemiological profile and lethality of visceral leishmaniasis/human immunodeficiency virus co-infection in an endemic area in Northeast Brazil”. Revista da Sociedade Brasileira de Medicina Tropical, n. 54, 2021.
MALTA, D. C. et al. “Mortalidade de adolescentes e adultos jovens brasileiros entre 1990 e 2019: uma análise do estudo Carga Global de Doença”. Ciência e Saúde Coletiva, vol. 26, 2021.
MINISTÉRIO DA SAÚDE. Boletim Epidemiológico: HIV/Aids 2024. Brasília: Ministério da Saúde, 2024. Disponível em: . Acesso em: 26/10/2024.
MINISTÉRIO DA SAÚDE. Protocolo clínico e diretrizes terapêuticas para profilaxia pós-exposição (PEP) de risco à infecção pelo HIV, IST e hepatites virais. Brasília: Ministério da Saúde, 2023. Disponível em: . Acesso em: 26/10/2024.
MONTANA, J. F. et al. “The HIV epidemic in Colombia: spatial and temporal trends analysis”. BMC Public Health, vol. 21, n.1, 2021.
NIK, J. A. A. et al. “Leong Bin Abdullah MFI: posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients”. PLoS One, vol. 3, n. 17, 2022.
OLIVEIRA, E. V.; MARTINS, W. “Principais fatores do crescimento de HIV na terceira idade”. Boletim de Conjuntura (BOCA), vol. 6, n. 17, 2021.
PEARSON, C. A, et al. “Internalized HIV Stigma predicts suboptimal Retention in Care among people living with HIV in the United States”. AIDS Patient Care STDS, vol. 5, n 35, 2021.
RIVERA-PICÓN, C. et al. “Differences in Resilience, Psychological Well-Being and coping strategies between HIV patients and diabetics”. Healthc, vol. 2, n 10, 2022.
VIEIRA, G. N. et al. “!O HIV/AIDS entre os jovens no Brasil: revisão integrativa da literatura”. Health Bios, vol. 1, n. 2, 2021.
WANG, X. et al. “Fear of progression, anxiety, and Depression in patients with Advanced Melanoma in the COVID-19 and Post-COVID-19 era”. Front Psychiatry, vol. 13, 2022.
WHO - World Health Organization. World Aids Day. Genebra: WHO; 2021 Disponível em: . Acesso em: 23/04/2024.
YIMER, A. et al. “Prevalence of misconception about HIV/AIDS transmission and associated factors among reproductive age women in Ethiopia: a nationwide study”. BMC Infectious Diseases, vol. 24, n. 1, 2024.